{"id":"W2606696169","doi":"10.18632/oncotarget.17005","title":"Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer","year":2017,"lang":"en","type":"article","venue":"Oncotarget","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Olaparib; Medicine; Oncology; Internal medicine; Ovarian cancer; PARP inhibitor; Response Evaluation Criteria in Solid Tumors; BRCA mutation; Breast cancer; Carboplatin; Cancer; Chemotherapy; Progressive disease; Cisplatin; Poly ADP ribose polymerase; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003016496,0.0001818339,0.0002825532,0.0003907985,0.000176179,0.000587228,0.0002442738,0.0004959449,0.001704198],"category_scores_gemma":[0.002059175,0.0001276352,0.0001887087,0.0004638408,0.0001627004,0.000380352,0.0002514631,0.0006356836,0.0003791316],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000275272,"about_ca_system_score_gemma":0.0002357001,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001366368,"about_ca_topic_score_gemma":0.001783046,"domain_scores_codex":[0.9998953,0.00001982257,0.00001254766,0.00002448092,0.00002553479,0.00002238156],"domain_scores_gemma":[0.9992423,0.0002785009,0.0002311488,0.00002390167,0.00008957217,0.0001346663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005137735,0.00003278368,0.9919086,0.00001228727,0.00002741469,0.0001206245,0.00002159578,0.0002144908,0.0002249114,0.00002707187,0.0006053884,0.00629095],"study_design_scores_gemma":[0.00003757931,0.0002182617,0.9963498,0.00002526263,0.00005984518,0.000622338,0.0001153971,0.001225156,0.0001718171,0.0001090847,0.001057768,0.000007503729],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994212,0.00233252,0.0001069446,0.0003823616,0.00004085813,0.00001479687,0.0007592552,0.00001111669,0.002140057],"genre_scores_gemma":[0.998504,0.0004089981,0.00007136359,0.0000610783,0.00004008575,0.00001094508,0.0006020116,0.000002533217,0.0002990084],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001704198,"threshold_uncertainty_score":0.005701065,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02152857503092633,"score_gpt":0.3581540459406864,"score_spread":0.3366254709097601,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}